Financial & Business News

Pre-Treatment with blarcamesine entirely prevented Abeta-induced cognitive decline Confirmed significant biomarker-response in hippocampus NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today reported a peer-reviewed publication in the journal Neuroscience Letters, titled “Prevention of memory impairment and hippocampal injury with blarcamesine in an Alzheimer's disease model.”1 This study shows that a pre-treatment with blarcamesine prevented Amyloid beta-induced memory impairment and brain oxidative injury suggesting that blarcamesine is an attractive candidate for Alzheimer's disease pharmacological prevention.

Highlights: Secretary Nielsen joins the board of directors of Allied USA. Secretary Nielsen is a leading expert on United States national security matters and has advised government agencies, private sector companies, international organizations, and NGOs on assessing their risk posture and increasing their resiliency.

Lithium prices have rebounded from lows, and Sigma Lithium stands to benefit if prices remain stable around US$900/ton for concentrate. SGML's low-cost structure and planned capacity expansion position it for strong margin and cash flow recovery by 2026-2027. Valuation upside is significant, with potential for shares to double by YE28 if lithium prices hold or improve.

Saniona to receive US $42.5 million upfront; potential for development, regulatory and sales milestone payments in addition to royalties on future net sales Jazz obtains exclusive worldwide rights to develop and commercialize preclinical asset SAN2355 in epilepsy and other potential indications For U.S. media and investors only DUBLIN and COPENHAGEN, Denmark , Aug. 20, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Saniona (Nasdaq OMX: SANION) today announce that the companies have entered into a global license agreement for Jazz to obtain exclusive worldwide rights to develop SAN2355, a highly differentiated, subtype-selective Kv7.2/Kv7.3 activator in preclinical development for epilepsy and other potential indications, designed to overcome the limitations of non-selective Kv7-targeting compounds. Jazz will lead and fund further development, regulatory submissions, and global commercialization activities.

WORCESTER, MA / ACCESS Newswire / August 20, 2025 / SideChannel, Inc. (OTCQB:SDCH) ("SideChannel"), a leading provider of cybersecurity services and technology to emerging and middle market companies, debuted its Threat Intelligence Labs, Threat Mitigation platform, and related services at DEF CON 33 in Las Vegas. The new Insider Threat practice focuses on bringing research and intelligence to assessing, managing, and mitigating risk exposures associated with insider threats for enterprises across all verticals.

The Investment is part of BrainsWay's ongoing strategy to acquire minority positions in leading U.S. mental health providers to help them raise awareness for and expand access to transformative care The Investment is part of BrainsWay's ongoing strategy to acquire minority positions in leading U.S. mental health providers to help them raise awareness for and expand access to transformative care

Flexential Secures Approximately $1B in Capital Investment to Drive Next-Generation Data Center Development SAN FRANCISCO , Aug. 20, 2025 /PRNewswire/ -- GI Partners, a leading private investment firm, today announced the simultaneous closing of investments by an oversubscribed, single-asset continuation vehicle and GI Data Infrastructure in Flexential, a leading provider of secure and flexible data center solutions. Both the continuation vehicle, anchored by funds managed by Hamilton Lane (Nasdaq: HLNE), and the GI Data Infrastructure investment offered existing GI Partners limited partners the option to receive liquidity and provide Flexential with additional equity capital to meet rising demand from enterprise and AI customers.

CHARLOTTE, N.C. , Aug. 20, 2025 /PRNewswire/ -- Erica, the most widely adopted AI-driven virtual financial assistant, is a central gateway to serving clients – assisting nearly 50 million users since launch, surpassing 3 billion client interactions, and now averaging more than 58 million interactions per month.

Experienced commercial and biopharmaceuticals leader to spearhead launch strategy and global market readiness for ersodetug Experienced commercial and biopharmaceuticals leader to spearhead launch strategy and global market readiness for ersodetug

NEW BRIGHTON, Minn.--(BUSINESS WIRE)--APi Group Corporation (NYSE: APG) (“APi” or the “Company”) today announced that its senior leadership will be participating in a fireside chat during the Jefferies Industrial Conference on Wednesday, September 3rd at 8:10 a.m. ET. The live webcast link and archived replay will be available in the “Events” area on the Investor Relations page of APi's website at www.apigroupinc.com. Interested parties should check the Company's website for any schedule update.